MedTrace Logo

Thoraflex Hybrid Post-Market Study

NCT03414866 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 182

Last updated 2025-07-09

No results posted yet for this study

Summary

This is a global, prospective non-interventional, multi-centre, post-market study of the Vascutek Thoraflex™ Hybrid system in patients with acute thoracic aortic syndrome, subacute/chronic dissection of the aorta and aortic aneurysm.

Conditions

  • Acute Aortic Dissection
  • Aortic Rupture
  • Penetrating Aortic Ulcer
  • Aortic Dissection
  • Aortic Aneurysm, Thoracic

Interventions

BEHAVIORAL

EQ-5D-5L QOL questionnaire

Written questionnaire

Sponsors & Collaborators

  • Vascutek Ltd.

    lead INDUSTRY

Principal Investigators

  • Malakh Shrestha, Prof. Dr. · Hannover Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-25
Primary Completion
2025-04-25
Completion
2026-07-31

Countries

  • Canada
  • Germany
  • Italy
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03414866 on ClinicalTrials.gov